- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT00939432
Taboo Perception of Incontinence, Depression and Cancer
The Greatest Taboo- Urinary Incontinence, Depression and Cancer
Objective/study hypothesis To evaluate how much of a taboo UI is and how it compares to other medical conditions that may also pose a taboo issue like depression and cancer.
Background Urinary incontinence (UI) is a highly prevalent condition with more than 200 million people worldwide being affected. While physical health does not necessarily have to be impaired much, restriction of social activities leads to isolation, a significant reduction in quality of life and will often bring about subsequent morbidity. Despite its prevalence, many patients suffering from UI go undiagnosed and untreated. Patients often hesitate to report the problem, and health care professionals often do not ask about it. In a study Minassian (2003) estimated that just one in four patients actively seeks medical attention. The reason for this may lie in the shame, embarrassment, and stigma associated with this condition, which in turn pose significant barriers to seeking professional treatment. Although mentioned by many narrative reviews and included in some epidemiological papers on UI, surprisingly we found no data addressing the taboo of UI exclusively. The aim of our study therefore was
Methods/Design A 13-question self-administered questionnaire was developed and face validity tested by 2 of the authors (KH, EH). The anonymous questionnaire contained simple questions on gender and age and then asked yes/no questions on whether test persons knew people with UI, or suspected other people to be incontinent, if they would address this issue with the suspected person, and if they thought that UI was a taboo issue in the society. On a scale from 0 - 10 they were then asked to grade the amount of embarrassment and anxiety if they themselves were incontinent, compared to depression or cancer. A few questions on knowledge of the condition of UI and to whom test persons would turn to in case of UI concluded the short questionnaire, which took about 5 minutes to fill in. A convenience sample of 150 test persons from waiting areas of a teaching hospital and in private practices of general practitioners in Austria agreed to take part in the study, with an additional 10 persons (6.2%) declining after being informed about the subject. Data were analysed with the SPSS 10.0.5 software package using the U-test, Chi-square-test, Yates-correction, Fisher's exact test and Kolmogorov-Smirnov normality test where appropriate.
Study Overview
Status
Conditions
Study Type
Enrollment (Actual)
Contacts and Locations
Study Locations
-
-
-
Vienna, Austria, 1090
- Medical University of Vienna Austria
-
-
Participation Criteria
Eligibility Criteria
Ages Eligible for Study
Accepts Healthy Volunteers
Genders Eligible for Study
Sampling Method
Study Population
Description
Inclusion Criteria:
- Subjects older than 18 years willing to take part in study mentally capable to understand and fill in anonymous questionnaire
Exclusion Criteria:
- incomplete questionnaire
Study Plan
How is the study designed?
Design Details
- Observational Models: Ecologic or Community
- Time Perspectives: Cross-Sectional
Cohorts and Interventions
Group / Cohort |
|---|
|
Gender
male/female
|
|
Age
18-100 years
|
|
Educational level
primary school, secondary school, university
|
What is the study measuring?
Primary Outcome Measures
Outcome Measure |
Time Frame |
|---|---|
|
Perception of given medical condition as a taboo issue
Time Frame: single point in time
|
single point in time
|
Secondary Outcome Measures
Outcome Measure |
Time Frame |
|---|---|
|
Knowledge of treatment options of incontinence
Time Frame: single point in time
|
single point in time
|
|
Knowledge of friends or relatives with incontinence
Time Frame: single point in time
|
single point in time
|
Collaborators and Investigators
Sponsor
Study record dates
Study Major Dates
Study Start
Primary Completion (Actual)
Study Completion (Actual)
Study Registration Dates
First Submitted
First Submitted That Met QC Criteria
First Posted (Estimate)
Study Record Updates
Last Update Posted (Estimate)
Last Update Submitted That Met QC Criteria
Last Verified
More Information
Terms related to this study
Additional Relevant MeSH Terms
Other Study ID Numbers
- EK 453/2008
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.
Clinical Trials on Gender Differences
-
Radboud University Medical CenterTheia Foundation, Zilveren Kruis AchmeaTerminatedImproved Recognition of Partner Abuse | Gender Differences in Discussing Partner Abuse | Abused Women's Expectations,Experiences | Abused Women's Health Care UtilisationNetherlands
-
Eskisehir Osmangazi UniversityRecruitingMajor Depressive Disorder (MDD) | Resilience, Psychological | Social Stigma | Gender Differences | Self StigmaTurkey (Türkiye)
-
Cairo UniversityCompletedLow Back Pain | Chronic | Gender Differences | Musculoskeletal AssessmentEgypt
-
Anna Stanhewicz, PhDCompleted
-
Children's Hospital Los AngelesRecruiting
-
Enes CelikNot yet recruitingPerfusion Index | Position DifferencesTurkey (Türkiye)
-
TriHealth Inc.Completed
-
Universitaire Ziekenhuizen KU LeuvenCompleted
-
Brigham and Women's HospitalNot yet recruitingSex Differences | Circadian MisalignmentUnited States
-
Johann Wolfgang Goethe University HospitalCompletedDifferences in Laboratory Coagulation ParametersGermany